Scienture (NASDAQ:SCNX) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Scienture (NASDAQ:SCNX) posted its quarterly earnings results on Thursday. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.02, FiscalAI reports. The business had revenue of $0.34 million during the quarter, compared to analysts’ expectations of $1.96 million.

Scienture Trading Down 2.2%

Shares of NASDAQ:SCNX traded down $0.01 on Friday, hitting $0.46. 27,382,480 shares of the company were exchanged, compared to its average volume of 2,424,116. The stock’s 50 day moving average price is $0.38 and its 200 day moving average price is $0.40. The firm has a market capitalization of $18.49 million, a P/E ratio of -0.18 and a beta of 3.26. Scienture has a 1-year low of $0.24 and a 1-year high of $2.60.

Hedge Funds Weigh In On Scienture

An institutional investor recently bought a new stake in Scienture stock. Virtu Financial LLC purchased a new position in Scienture Holdings, Inc. (NASDAQ:SCNX) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned approximately 0.22% of Scienture as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 5.68% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Scienture in a research note on Wednesday, June 24th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Scienture presently has an average rating of “Hold” and an average price target of $1.50.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.